- 産業: Government
- Number of terms: 33950
- Number of blossaries: 0
- Company Profile:
United States Department of Health and Human Services, Radiation Emergency Medical Management
A monoclonal antibody being studied in the treatment of kidney cancer, melanoma, and pulmonary fibrosis. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-TGF-beta monoclonal antibody GC1008 binds to the protein transforming growth factor-beta (TGFß) and may block the growth of cancer cells that make it. Also called GC1008.
Industry:Health care
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the surface of some tumor cells. This may kill the tumor cells. Anti-TRAIL R1-mAb is a type of monoclonal antibody. Also called HGS-ETR1 and mapatumumab.
Industry:Health care
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. Anti-TRAIL R2 mAb HGS-ETR2 is a type of monoclonal antibody. Also called HGS-ETR2 and lexatumumab.
Industry:Health care
A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-VEGFR monoclonal antibodies bind to receptors for vascular endothelial growth factor (VEGF) and keeps VEGF from binding to them. This may stop the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent.
Industry:Health care
A substance being studied in the treatment of breast cancer that has come back. It binds to receptors for a protein called vascular endothelial growth factor (VEGF). This keeps VEGF from binding to the receptors and may stop the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent and a type of monoclonal antibody. Also called IMC-1121B and ramucirumab.
Industry:Health care
Small pieces of DNA that can bind to specific molecules of RNA and block the cell’s ability to use the RNA to make a protein or work in other ways. Antisense DNA may be used to block the production of proteins needed for cell growth. It is being studied in the treatment of many types of cancer.
Industry:Health care
Small pieces of RNA that can bind to specific molecules of RNA and block the cell’s ability to use the RNA to make a protein or work in other ways. Antisense RNA may be used to block the production of proteins needed for cell growth. It is being studied in the treatment of many types of cancer.
Industry:Health care
A drug used to treat nausea and vomiting caused by cancer treatment. It is a type of serotonin receptor antagonist and a type of antiemetic. Also called dolasetron mesylate.
Industry:Health care
A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.
Industry:Health care
A substance being studied in the treatment of head and neck cancer. It may kill cancer cells by carrying an anticancer drug into the tumor. It is a type of platinum compound.
Industry:Health care
